Meddenovo
Meddenovo transforms drug design through leveraging AI, molecular modelling, and the unique properties of cyclic peptides to create innovative therapeutic solutions.
Meddenovo has raised €1.4M across 2 funding rounds from 2 investors, most recently a round in May 2025. Based in Lyon, France; active in Healthtech. Data as of 28 Oct 2026.
Lyon, Francemeddenovo.com ↗
Total raised
€1.4M
€1,396,266
Funding rounds
2
Investors
2
distinct backers
Active since
2024-07
latest 2025-05
Funding by year
EUR raised per yearMeddenovo — funding by year — interactive chart.
Data table
| Meddenovo — funding by year | |
|---|---|
| 2024 | €1.0M |
| 2025 | €396k |
Signals
High confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-27 | Other | €396k | INVEST 101 | View deal → |
| 2024-07-31 | Pre-Seed | €1.0M | ACT Venture Capital | View deal → |
Investors
2Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData